Carla Blin

939 total citations
10 papers, 378 citations indexed

About

Carla Blin is a scholar working on Molecular Biology, Aging and Cancer Research. According to data from OpenAlex, Carla Blin has authored 10 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 3 papers in Aging and 3 papers in Cancer Research. Recurrent topics in Carla Blin's work include Pluripotent Stem Cells Research (4 papers), CRISPR and Genetic Engineering (4 papers) and FOXO transcription factor regulation (3 papers). Carla Blin is often cited by papers focused on Pluripotent Stem Cells Research (4 papers), CRISPR and Genetic Engineering (4 papers) and FOXO transcription factor regulation (3 papers). Carla Blin collaborates with scholars based in United Kingdom, United States and Germany. Carla Blin's co-authors include Steven M. Pollard, Raul Bardini Bressan, María Ángeles Marqués‐Torrejón, Vivien Grant, Ester Gangoso, Sabine Gogolok, Harry Bulstrode, Christine Ender, Sladjana Gagrica and Kirsty M. Ferguson and has published in prestigious journals such as Nature Communications, Genes & Development and Development.

In The Last Decade

Carla Blin

10 papers receiving 375 citations

Peers

Carla Blin
Raul Bardini Bressan United Kingdom
Zulekha A. Qadeer United States
Laure Bihannic United States
Sladjana Gagrica United Kingdom
Falk Hertwig Germany
Sabine Gogolok United Kingdom
Raul Bardini Bressan United Kingdom
Carla Blin
Citations per year, relative to Carla Blin Carla Blin (= 1×) peers Raul Bardini Bressan

Countries citing papers authored by Carla Blin

Since Specialization
Citations

This map shows the geographic impact of Carla Blin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carla Blin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carla Blin more than expected).

Fields of papers citing papers by Carla Blin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carla Blin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carla Blin. The network helps show where Carla Blin may publish in the future.

Co-authorship network of co-authors of Carla Blin

This figure shows the co-authorship network connecting the top 25 collaborators of Carla Blin. A scholar is included among the top collaborators of Carla Blin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carla Blin. Carla Blin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Ferguson, Kirsty M., et al.. (2024). Modelling quiescence exit of neural stem cells reveals a FOXG1-FOXO6 axis. Disease Models & Mechanisms. 17(12). 1 indexed citations
2.
Robertson, Faye, Eoghan O’Duibhir, Ester Gangoso, et al.. (2023). Elevated FOXG1 in glioblastoma stem cells cooperates with Wnt/β-catenin to induce exit from quiescence. Cell Reports. 42(6). 112561–112561. 5 indexed citations
3.
Ferguson, Kirsty M., Carla Blin, Neza Alfazema, et al.. (2022). Lrig1 regulates the balance between proliferation and quiescence in glioblastoma stem cells. Frontiers in Cell and Developmental Biology. 10. 983097–983097. 7 indexed citations
4.
Marqués‐Torrejón, María Ángeles, Charles A.C. Williams, Benjamin Southgate, et al.. (2021). LRIG1 is a gatekeeper to exit from quiescence in adult neural stem cells. Nature Communications. 12(1). 2594–2594. 59 indexed citations
5.
Bressan, Raul Bardini, Benjamin Southgate, Kirsty M. Ferguson, et al.. (2021). Regional identity of human neural stem cells determines oncogenic responses to histone H3.3 mutants. Cell stem cell. 28(5). 877–893.e9. 49 indexed citations
6.
Wagstaff, Laura, et al.. (2019). Reprogramming of Fibroblasts to Oligodendrocyte Progenitor-like Cells Using CRISPR/Cas9-Based Synthetic Transcription Factors. Stem Cell Reports. 13(6). 1053–1067. 17 indexed citations
7.
Southgate, Benjamin, Eoghan O’Duibhir, Niall Quinn, et al.. (2018). An efficient and scalable pipeline for epitope tagging in mammalian stem cells using Cas9 ribonucleoprotein. eLife. 7. 42 indexed citations
8.
Bressan, Raul Bardini, Ester Gangoso, Carla Blin, et al.. (2017). Efficient CRISPR/Cas9-assisted gene targeting enables rapid and precise genetic manipulation of mammalian neural stem cells. Development. 144(4). 635–648. 72 indexed citations
9.
Bulstrode, Harry, María Ángeles Marqués‐Torrejón, Kirsty M. Ferguson, et al.. (2017). Elevated FOXG1 and SOX2 in glioblastoma enforces neural stem cell identity through transcriptional control of cell cycle and epigenetic regulators. Genes & Development. 31(8). 757–773. 92 indexed citations
10.
Okawa, Satoshi, Sladjana Gagrica, Carla Blin, et al.. (2016). Proteome and Secretome Characterization of Glioblastoma-Derived Neural Stem Cells. Stem Cells. 35(4). 967–980. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026